The Institute for Juvenile Research is a research, demonstration and training center housed in the Department of Psychiatry, College of Medicine, University of Illinois at Chicago. The institute has more than 40 faculty members and 65 professional staff members.

During the past decade, Institute for Juvenile Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Institute for Juvenile Research" are "Autism Spectrum Disorders" (2 trials). Many other conditions were trialed in "Institute for Juvenile Research" in a lesser frequency.

Most popular intervention types in "Institute for Juvenile Research" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Arbaclofen" (1 trials) and "STX209 (arbaclofen)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute for Juvenile Research" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Institute for Juvenile Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Institute for Juvenile Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Institute for Juvenile Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".